跳至主要内容
临床试验/JPRN-UMIN000007439
JPRN-UMIN000007439已完成1 期

The safety, efficacy and the predictive factors of efficacy of beclomethasone dipropionate (BDP) for acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation - The safety, efficacy and the predictive factors of efficacy of BDP for acute GVHD

Hematology,Graduate School of Medicine, Osaka City University0 个研究点目标入组 26 人开始时间: 2012年3月5日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients requiring systemic steroid treatment for grade 2 acute GVHD of skin and/or liver 2. Patients who cannot intake oral BDP 3. Uncontrollable infection in the gastrointestinal tract 4. Pregnant or possibility pregnant woman 5. Inappropriate to participate in this study as judged by the physician in charge

研究者

发起方
Hematology,Graduate School of Medicine, Osaka City University

相似试验